Study of matrix metalloproteinases and their inhibitors in prostate cancer. - Wikidata - wikimedia - TriplyDB

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

http://www.wikidata.org/entity/Q33708162

about

Prostate cancer relevant antigens and enzymes for targeted drug delivery Physical biology in cancer. 5. The rocky road of metastasis: the role of cytoskeletal mechanics in cell migratory response to 3D matrix topography Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis Angiogenesis in prostate cancer: onset, progression and imaging.Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.Epithelial-mesenchymal transition in prostatic disease.TIMP4 expression is regulated by miR-200b-3p in prostate cancer cells.Proteases as prognostic markers in human and canine cancers.Dickkopf-3 regulates prostate epithelial cell acinar morphogenesis and prostate cancer cell invasion by limiting TGF-β-dependent activation of matrix metalloproteases.Unripe Rubus coreanus Miquel suppresses migration and invasion of human prostate cancer cells by reducing matrix metalloproteinase expression.Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival.Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients.Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial.Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer.Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions.Study of the expression of toll-like receptors in different histological types of colorectal polyps and their relationship with colorectal cancer.Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.

P2860

Q27013843-7A638267-1430-43D3-9164-077DF64D59D8 Q27021875-6B490876-B1CC-4917-B104-B11C7D452B00 Q35741034-DD4291B0-7DAB-4728-B9E9-C7BF65A73BD8 Q36827512-AA36B1B3-7B6F-4233-BC8D-6C50B153777C Q38041673-B2CFF1AD-1AD8-43FA-A445-5CE109A73E39 Q38107451-044C2BEB-D8C7-4A6C-8B00-5CFF4CD45F28 Q38628753-BD501547-5E6D-4FE1-BAAA-4BCE39D68ABF Q38724024-9DC0CDEF-2716-45D9-B31E-725A5BDEF2E4 Q38823174-77585047-0782-4CFD-94A1-FB208488FA34 Q38824669-7BD27A5C-5A47-4EB0-8F26-909B3C986FA7 Q38965194-87BC3E72-310C-4806-9D23-9BE41689320D Q39412611-4A408F89-A552-4750-888E-A23097C75E8D Q39552861-E7B3756B-A133-4204-AE99-62AF5267FB22 Q39620822-01ADFDF3-075B-49C9-AB5D-0729292C4362 Q40112666-25314D11-C41B-4262-B9CD-B09382681508 Q40798009-635E682E-E004-461A-9920-F4354370AD84 Q41548112-F8DDFBD0-CFF3-41E0-9FAF-D063BE247839 Q47925738-A546FB6B-C758-4B53-BC15-F3599978F755 Q47970174-241B9B5F-4399-46F9-9EE3-D64E9717504F Q54321617-27F6BCFB-37A9-4B57-91BE-342CC48E915F Q54404821-675C74DD-6C70-42C9-9E46-2BED33D7C8C2 Q54777883-33832E49-B9B6-4AC8-9227-1C6B0AD1EBD9

P2860

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

http://www.wikidata.org/entity/Q33708162

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

@ast

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

@en

type

label

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

@ast

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

@en

prefLabel

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

@ast

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

@en

P1433

Q33708162-EC4914CC-6BF1-41D5-845D-3F2C3965D029

P1476

Q33708162-212A92AB-ED5C-404C-B557-5568E33F497B

P2093

Q33708162-21C20476-6B19-4D5F-AABE-B92291D20188

Q33708162-2FB87120-F6C3-440C-A7BA-9756FD49ED86

Q33708162-58A8232A-6B86-45F5-B567-444F3F16E528

Q33708162-65A6F01B-D4D7-4EB0-89DA-3220C90C9A42

Q33708162-9C8FB3FD-3190-424E-B580-35E8580F5484

Q33708162-C480FC6D-79BA-4859-839A-E2AF9F7513BE

Q33708162-F417D0CC-6AA6-44A6-8532-4A191D59D6C4

P2860

Q33708162-00EAFC1A-C995-4246-937C-968858C2AEF3

Q33708162-09A0CD81-22A2-465B-8FA2-8F2D955EC080

Q33708162-21607166-4FB0-457D-85D5-01F3C5700048

Q33708162-221F4FD6-6350-434F-82FF-E5A359AC0D6F

Q33708162-22B5B1F2-88A7-479C-8673-DB0E5A17E727

Q33708162-25D2326C-80C0-4AE7-907C-DA3191FC89A6

Q33708162-2629F1AD-4189-445D-B033-7D91329330F2

Q33708162-33BD8C21-990D-4A68-87F1-51D249C60213

Q33708162-34322114-543F-44B7-B61C-B46CBF72ED80

Q33708162-3D48D7FA-5281-4063-998B-18E759057D5D

P2888

Q33708162-DFB2E62B-1FA3-4A74-8938-6DFBC32BF44B

P304

Q33708162-30BD782C-B663-4B1A-A37B-17E2F2271A4A

P31

Q33708162-09025563-D0A9-41D2-ABF4-E9441DCB66C5

P356

Q33708162-89F77CE5-87B4-4972-8BFE-CF274FC2FFB5

P407

Q33708162-8B1EF362-3CA8-4824-BFD0-F0BDAF661E7B

P433

Q33708162-05A82A59-C0AC-4124-98C0-8671C9FD185B

P478

Q33708162-898350B9-815F-4170-8532-71C7A62F1AC0

P577

Q33708162-6A9CFF51-29EF-45D6-B1E6-363E15126BC0

P5875

Q33708162-4F776E6D-60FD-4FF8-93D7-17C81D490BF1

P6179

Q33708162-1951FA07-43D9-45B9-9F07-0F6E8DE55921

P698

Q33708162-4C1A2583-2631-4964-8615-2D3E0F3CB7D5

P932

Q33708162-F87A6678-8C35-4F17-B0CD-1F48BD71F8D9

P356

P1433

British Journal of Cancer

P1476

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

@en

P2093

A Suárez

http://www.w3.org/2001/XMLSchema#string

F J Vizoso

http://www.w3.org/2001/XMLSchema#string

J M Fernández

http://www.w3.org/2001/XMLSchema#string

J M González

http://www.w3.org/2001/XMLSchema#string

L O González

http://www.w3.org/2001/XMLSchema#string

S Escaff

http://www.w3.org/2001/XMLSchema#string

S González-Reyes

http://www.w3.org/2001/XMLSchema#string

P2860

The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction

Cluster analysis and display of genome-wide expression patterns

Molecular pathology of prostate cancer

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study

High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase

Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis

Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells

P2888

P304

922-929

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605569

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41452529

http://www.w3.org/2001/XMLSchema#string

P6179

1011760156

http://www.w3.org/2001/XMLSchema#string

P698

20160732

http://www.w3.org/2001/XMLSchema#string

P932

2833257

http://www.w3.org/2001/XMLSchema#string